News
MyWay Digital Health has secured £3m in funding to scale its diabetes management platform, which is used across several NHS regions. The Edinburgh-based company, spun out of the University of Dundee in 2017, employs 30 staff across Dundee, Edinburgh and London. It develops data-driven technology to support the management of long-term conditions, with a particular [...]
NHS England has introduced a new depreciation timeline for CIS1, requiring trusts to move completely to CIS2 by 28 February 2027, when access to CIS1 will be removed. Andrew Harrison, director, product management - international at Imprivata, discusses the drive for more secure access to electronic patient record systems that is affecting hospitals in the [...]
Ease Health has launched with US$41m in early-stage funding to expand adoption of its behavioural health software platform among large providers treating mental health and substance use conditions. The New York-based startup has developed a platform that combines admissions processing, patient management and billing tools for behavioural health providers. Many providers rely on two separate [...]
Generate:Biomedicines has raised US$400m in the year’s biggest biotech IPO so far, with proceeds earmarked for clinical trials and R&D on its artificial intelligence platform. The drug developer, which focuses on immunology and inflammation as well as oncology, priced shares at US$16 and began trading on the Nasdaq Global Market under the symbol GENB. [...]
Esperion Therapeutics has agreed to acquire Corstasis Therapeutics in a deal worth up to US$255m, adding a nasal spray treatment for heart failure-related fluid retention to its portfolio. Under the agreement, Esperion will pay US$75m in upfront cash for all outstanding Corstasis shares. Shareholders may also receive up to US$180m in additional payments linked to [...]
The NHS is the most trusted organisation for responsible AI use in the UK, according to a survey of citizens and public sector workers. The findings come from the 2026 UK Public Sector AI Adoption Outlook, conducted by Censuswide on behalf of software firm Appian, which surveyed 1,000 UK public sector workers and 1,000 UK [...]
Alcidion today announces that Miya Precision Concept Detection has been included on the Australian Register of Therapeutic Goods (ARTG – #522634) as a Class 1 Medical Device. The capability has also been successfully registered as a Class 1 Medical Device with the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom. Concept Detection [...]
By Sanius Health Gene therapy has now moved decisively from scientific ambition to clinical reality, and in doing so, it has redefined what is possible for patients living with severe genetic conditions such as sickle cell disease, where curative intent is no longer a distant aspiration but a regulated, deployable therapeutic pathway. What we are [...]
By John Romano, co-founder & chief strategy Officer, Gifthealth For pharmacists, a daily challenge is not just dispensing medication – it is managing the complex, often chaotic, journey of patients with gastrointestinal (GI) diseases. More than 60 million people in the US are affected by digestive diseases. Yet many patients struggle to effectively access life-changing [...]
Munich-based Noxon has secured seed funding to advance its muscle-computer interface, a wearable technology designed to monitor and stimulate muscles during therapy. The medtech startup, founded in 2022 as a spin-off from three universities, is developing a device that combines continuous muscle monitoring with neuromuscular electrical stimulation (NMES). NMES is a therapy that uses small [...]
